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Because appropriate clinical management is guided by the
nature of the mass, accurate diagnosis of discrete hepatic
masses is very important. Possible treatments range from
supportive care for advanced metastatic lesions to partial
hepatectomy for primary carcinomas. Despite recent
improvement, radiological imaging does not always allow
precise characterization of the lesions. Serological markers
(such as alpha fetoprotein) can be useful in narrowing the
differential diagnosis when they are markedly elevated
but a substantial number of patients unfortunately do not
have high levels of these markers at the time of presenta-
tion. Therefore, a tissue diagnosis is often required to
guide subsequent management. Fine needle aspiration
biopsy (FNA) under image guidance has gained increasing
acceptance as the diagnostic procedure of choice for
patients with focal hepatic lesions. It can be performed
percutaneously or endoscopically. This review will discuss
fine needle aspiration biopsy of liver from a pathologist's
perspective. The review will also address the cytology and
the pitfalls of some of the more commonly encountered
hepatic lesions as well as those that may pose diagnostic
challenges.
Currently, there are several diagnostic procedures to
obtain preoperative tissue diagnosis to guide subsequent
therapy. They include image guided fine needle aspiration
biopsy, blind percutaneous needle core biopsy, and tran-
sjugular needle core biopsy. Percutaneous needle core
biopsy without imaging guidance is excellent for diagnos-
ing diffuse liver diseases such as hepatitis, cirrhosis, and
metabolic diseases. Accuracy is superb and the complica-
tion rate is low. However, it is not indicated for focal, dis-
crete hepatic lesions. To minimize the risk of hemorrhage,
transjugular approach is often reserved for patients with a
bleeding diathesis. Fine needle aspiration biopsy (FNA)
under image guidance has gained increasing acceptance as
the diagnostic procedure of choice for patients with focal
hepatic lesions. It can be performed percutaneously or
endoscopically. The latter approach is technically difficult
for lesions located far away from the tip of the echoeno-
doscope and lesion near the 2nd or 3rd portion of the duo-
denum because of poor visualization [1]. FNA may also
be performed at laparoscopy or laparotomy under direct
vision when imaged guided FNA fails to provide diagnos-
tic tissue [2].
This review is not intended to be exhaustive. Therefore,
the discussion is limited to the lesions that are more com-
monly encountered in day-to-day practice and those that
may pose diagnostic challenges.
Operating characteristics of FNA
In experienced hands, FNA is safe, minimally invasive,
accurate, and cost effective. The specificity of FNA biopsy
of the liver approaches 100% and the sensitivity ranges
from 67–100%, averaging about 85% [3-9]. FNA alone is
superior to core biopsy alone because the needle is longer,
can be guided, and the procedure can be easily repeated
[10,11]. However, both methods are complimentary to
each other [10,12,13].
Complications of FNA
The occurrence of complications after hepatic FNA is rare
with about 0.5% minor complications, 0.05% major
complications requiring surgery, and less than 0.01%
mortality [14-17]. They are limited largely to hemorrhage.
The frequency of complications is often related to the vas-
cularity and the location of the lesions as well as the nee-
dle size [18]. Another concern is the subcutaneous
seeding of tumor along the needle tract during
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precutaneous liver FNA. The incidence varies with the
diameter of the needle, the number of passes, and the
amount of normal parenchyma around the lesion to be
traversed by the needle [7]. It is still an extremely rare
complication. For example, there are only a few case
reports of needle tract seeding when using needle of 23
gauge or less [19-21].
Contraindications of FNA
Absolute contraindications for FNA of liver include uncor-
rectable bleeding diathesis, a lack of a safe access route e.g.
vascular structure in the biopsy path, and uncooperative
patients.
Specimen preparation
It is crucial to handle the aspirate quickly and optimally in
order to minimize artifacts. Ideally, both direct smears
and cell block should be prepared for all FNA of livers.
Cell block preparation is especially useful if immunohis-
tochemical study is required for differential diagnosis.
Direct smears are made by spreading a small volume of
aspirated material on prelabeled slides which can be
either air-dried or fixed in 95% ethanol. The air-dried
smears are stained with a modified Giemsa stain. The
alcohol-fixed smears are stained with the Papanicolaou
method. A cell block is then prepared from residual mate-
rials rinsed from the needle.
Several studies have shown that the assistance of
cytopathologists during the procedure increases overall
accuracy [22-24]. The latter is attributed to the ability to
assess specimen adequacy at the time of biopsy and to
determine if additional tissue is required for diagnosis
and/or ancillary studies such as flow cytometry.
Clinical and radiological correlation
Although clinical and/or radiological findings cannot reli-
ably distinguish a primary hepatic malignancy from a
metastatic disease, they can help to narrow the differential
diagnosis. The age of the patient may suggest certain proc-
esses. For example, metastatic disease and primary hepa-
tocellular carcinoma (HCC) more frequently affect older
patients whereas benign lesions such as liver cell adenoma
and fibrolamellar variant of HCC tend to occur in younger
patients. Hepatoblastoma occurs primarily in infants
[25]. Patients with liver cell adenoma often have a history
of long term steroid use.
Another informative clue is the presence or absence of cir-
rhosis. For patients with cirrhosis, HCC is a more likely
finding in the United States [26]. However, 10–20% of
nonfibrolamellar HCCs occur in patients without cirrho-
sis. Fibrolamellar HCC always occurs in noncirrhotic liver.
A markedly elevated serum AFP level, >1,000 ng/ml, is
highly suggestive of HCC or in children, hepatoblastoma.
A moderate increase in serum AFP, however, is non-spe-
cific and can be seen in a wide variety of benign and
malignant conditions. Patients with fibrolamellar variant
of HCC may not demonstrate an elevated serum AFP
level.
The finding of a single, large mass with or without smaller
satellite lesions on imaging is more typical of a HCC
whereas metastatic lesions often present with multiple
lesions of similar size.
Cytology of normal and reactive liver
Aspirates of normal liver consist predominantly of hepa-
tocytes and scattered bile duct epithelial cells. Table 1
summarizes the cytologic features of these two types of
cells. Other cell types such as endothelial cells and
Kupffer's cells are infrequently noted. Occasionally, mes-
othelial cells and small bowel mucosa may be inadvert-
ently sampled depending on the approach. They should
not be mistaken for tumors.
Table 1: Cytology of normal hepatocytes and bile duct epithelium.
Hepatocytes Bile duct epithelium
Arrangement Singly, 2-dimensional small to large clusters, 
trabeculae of 2 to 3 cells layer thick
Picket fences with nuclear palisading, 
monolayered honeycomb sheets
Cells Polygonal to round Cuboidal to columnar
Cytoplasm Abundant dense granular* to vacuolated (lipid/
glycogen), pigments (lipofusin, bile, or 
hemosiderin)
Scant, pale
Nuclei
Round, centrally located, intranuclear 
cytoplasmic inclusions, nuclear clearing 
binucleation
Uniform, small, round, more condensed 
chromatin
Nucleoli Prominent Inconspicuous
*: cytoplasm appears red-orange, orange-brown, or blue green with Papanicolaou stain, and dark blue with Diff-Quik stain.World Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/5
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Cirrhosis may be sampled by FNA when a dominant nod-
ule mimics a HCC radiologically. The cytology of cirrhotic
liver is similar to that of normal liver. Occasionally, mark-
edly reactive hepatocytes may display significant cytolog-
ical atypia including variable nuclear size, increase
nuclear/cytoplasmic ratio, coarse chromatin, prominent
nucleoli, and frequent bi- or multinucleation. In some
instances, they may represent a dysplastic process.
Separating a "dysplastic" nodule and HCC in a cirrhotic
liver based on cytology alone can be difficult, if not
impossible, since their distinction is often based on archi-
tectural criteria [27,28]. For this reason, this constitutes a
potential source of false positive error [29].
Focal nodular hyperplasia and liver cell adenoma
Both focal nodular hyperplasia (FNH) and liver cell ade-
noma usually affect patients in their 3rd and 4th decades
with a female predominance [26]. The serum AFP level
and liver function test are often within normal ranges.
Focal nodular hyperplasia is usually asymptomatic and is
sometimes characterized by the presence of a central area
of low attenuation radiologically [30,31]. Patients with
liver cell adenoma may present with an acute abdomen
and may be associated with a history of steroid use
[32,33].
Cytologically, both lesions are composed of bland
appearing hepatocytes (Figure 1). For FNH, bile duct epi-
thelium and stromal fragments may be present. Aspirates
of liver cell adenoma characteristically contain hepato-
cytes only; however, evidence of hemorrhage and necrosis
may be noted [34,35]. In making a diagnosis of these enti-
ties, it is crucial that the needles are within the lesion and
only the lesions are sampled.
Hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common
primary hepatic malignancy [26]. The cytological appear-
ance of HCC varies with the degree of differentiation. The
diagnosis of moderately differentiated hepatocellular car-
cinomas is usually straightforward because they look like
normal liver while at the same time demonstrating obvi-
ous malignant features. At one end of the spectrum, the
tumor is well differentiated – it resembles liver but does
not look obviously malignant. On the opposite end of the
spectrum, the tumor is poorly differentiated – it is obvi-
ously malignant but may be difficult to appreciate its
hepatic origin.
Differentiation between well differentiated hepatocellular 
carcinoma and benign hepatic lesions
One very helpful diagnostic clue for well differentiated
HCC is the presence of one of the two characteristic
endothelial patterns. The first one is basketing – endothe-
lial cells wrap around groups or trabeculae of hepatocytes
(Figure 2). This pattern is observed in 50% of HCC but is
specific for HCC [36-39]. The pattern is seldom seen in
benign hepatic lesions or other malignancies. The other
endothelial pattern consists of traversing capillaries
through groups of hepatocytes (Figure 3). This pattern is
noted in over 90% of HCC but is less specific than the
"basketing" pattern since it can be seen in other malignan-
cies and rarely, some non-neoplastic liver conditions [38].
Focal nodular hyperplasia Figure 1
Focal nodular hyperplasia. Bland appearing hepatocytes form-
ing loosely cohesive sheets and clusters. Benign ductal epi-
thelium was also noted in the aspirate. (not shown) Patient 
had an asymptomatic isolated liver mass. The impression was 
that of a focal nodular hyperplasia (Papanicolaou stain, ×100).
Hepatocellular carcinoma Figure 2
Hepatocellular carcinoma. Spindle-shaped endothelial cells 
are noted at the edge of the thickened trabeculae of hepato-
cytes – basketing endothelial pattern (Papanicolaou stain, 
×200).World Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/5
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Other features that favor a well differentiated HCC over
benign hepatic lesions include acinar formation and the
presence of prominent "cherry red" nucleoli.
Ancillary studies may be helpful in differentiating benign
and neoplastic hepatocytes. Decrease or absent reticulin
staining or positive staining pattern outlining trabeculae
greater than three cells thickness support the diagnosis of
HCC [40,41]. Others have shown that the presence of
diffuse immunostaining with CD34 and Factor VIII also
favor HCC [41,42]. Positive AFP staining is reported in
40% of HCC, but negative staining does not rule out a
diagnosis of HCC [43]. DNA ploidy and staining for pro-
liferating cell nuclear antigen (PCNA) have shown some
promises, but there is substantial overlap in the patterns
of benign and neoplastic processes [44-46].
Differentiation between poorly differentiated 
hepatocellular carcinoma and metastatic 
adenocarcinoma
In many instances, a known history of primary tumor is
available and the task is to determine whether the mor-
phology of the liver lesion is compatible with that of the
known primary tumor. However, when a history is not
available, the questions that need to be addressed will be
"Is it primary?" or "Is it metastatic?" A markedly elevated
serum AFP level and the finding of a single lesion with or
without satellite lesions on imaging favor a primary
tumor over metastatic disease.
Cytologically, bile production, as evidenced by the pres-
ence of bile in the cytoplasm of malignant cells or in
canaliculi between malignant cells, is considered diagnos-
tic of HCC. Unfortunately bile is present in only half of
the cases [37,39,47]. Although the "basketing" endothe-
lial pattern is pathognomonic for HCC, it is often absent
in poorly differentiated tumors. The presence of "travers-
ing" capillaries is less specific and can be seen in some
metastatic lesions, particularly, renal cell carcinoma [38].
The key in diagnosing a poorly differentiated HCC is to
look for better differentiated cells, with more typical hepa-
tocytic features [48].
Immunocytochemistry is of little help in differentiating
poorly differentiated HCC from metastatic lesions
because of a lack of highly specific markers. Canalicular
staining pattern with antibodies against polyclonal carci-
noembryonic antigen (pCEA) and diffuse positive stain-
ing with endothelial cells markers (such as CD34, Factor
VIII) can help distinguish HCC from metastatic adenocar-
cinoma [38,49-51]. But positive staining with these mark-
ers is least often identified in poorly differentiated HCC.
Another relatively new marker, HepPar1, has been shown
to be quite specific and sensitive as a marker for HCC.
About 83% to 100% of HCC stained positive with
HepPar1 but only 4% to 15% of metastatic carcinomas
were positive [52,53]. Unfortunately, only 56% of poorly
differentiated HCC expressed HepPar1 [53].
Fibrolamellar variant of hepatocellular carcinoma
Fibrolamellar variant of HCC is rare, accounting for 1% to
2% of all cases of HCC. However, it is important to recog-
nize this variant because it has a better prognosis [26]. It
commonly occurs in patients younger than 35 years and
in a non-cirrhotic liver. The serum AFP level is often
within normal range. On radiological and gross
examination, fibrolamellar variant of HCC is character-
ized by a lobulated tumor mass with a central stellate scar.
The key diagnostic features on FNA are oncocytic neoplas-
tic cells and lamellar fibrosis. The neoplastic cells consist
of abundant eosinophilic, granular cytoplasm as a result
of numerous swollen mitochondria [54]. Lamellar
fibrosis is represented by the presence of dense fibrous tis-
sue with parallel rows of bland fibroblasts.
Cholangiocarcinoma
Cholangiocarcinoma accounts for 10% of all primary
hepatic malignancy and affects elderly patients [26]. Cyto-
logically, cholangiocarcinoma resembles that of adeno-
carcinoma arising from pancreato-biliary tract and many
other sites [35] (Figure 4). Therefore, its distinction from
HCC is usually straightforward, except for poorly
differentiated HCC. The presence of mucin staining favors
a diagnosis of cholangiocarcinoma over a HCC. In addi-
tion, cholangiocarcinoma is rarely positive for AFP and
HepPar 1 [52,55].
The diagnostic challenge for pathologists is to distinguish
cholangiocarcinoma from metastatic adenocarcinoma.
Hepatocellular carcinoma Figure 3
Hepatocellular carcinoma. Capillary transverses a group of 
hepatocytes. (Papanicolaou stain, ×100).World Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/5
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Because of much overlap, immunocytochemistry is not
helpful in the differential diagnosis. As a result, their dis-
tinction relies primarily on clinical history and morphol-
ogy. A history of known primary and the morphology of
hepatic lesions comparable to that of the primary tumor
favor a diagnosis of metastatic carcinoma over primary
cholangiocarcinoma. There are also certain helpful mor-
phologic clues. For example, the presence of extensive
necrosis and columnar neoplastic cells with nuclear pal-
isading would suggest a metastatic colonic adenocarci-
noma. Lobular mammary adenocarcinoma is often
composed of relatively monotonous neoplastic cells
arranged in single file.
Vascular neoplasms
Hemangiomas are the most common benign tumor of the
liver. They are often asymptomatic and are detected inci-
dentally in the work up of another disease. Since radio-
logic imaging is often diagnostic of hemangiomas, they
are only occasionally evaluated by FNA. The aspirates are
often bloody with few cellular components including
spindle-shaped endothelial cells, capillaries, and frag-
ments of fibrovascular connective tissue and smooth mus-
cle [56] (Figure 5). Suspected hemangioma is not
considered an absolute contraindication to FNA [57-59].
However, aspirating such lesions carries a low risk of hem-
orrhage particularly when large needles are used.
Angiosarcomas are uncommon. Their clinical presentation
is similar to that of HCC. Liver function test is often
deranged but the serum AFP level is not elevated. Angiog-
raphy may be helpful in diagnosis. Cytologically, the
tumor consists of single and loosely cohesive groups of
pleomorphic spindle shaped and/or epithelioid endothe-
lial cells in a hemorrhagic and necrotic background. Tubu-
lar structures, resembling capillaries, may be seen. The
differential diagnosis includes other sarcomas, both pri-
mary and metastatic.
Cystic lesions
Cystic hepatic lesions seldom undergo FNA. The differen-
tial diagnosis includes a wide variety of reactive and neo-
plastic conditions. Infections may result in cystic hepatic
lesions including abscesses and hydatid cysts. Liver
abscess can be pyogenic and amoebic. Pyogenic abscesses
are often polymicrobial and consist of numerous neu-
trophils and necrotic tissue on FNA. Amoebic abscesses,
on the contrary, contain few or no neutrophils. Periodic
acid-Schiff (PAS) or iron stains are helpful in identifying
trophozoites which are seen in about one third of the
cases [60].
Hydatid cysts are caused by the larvae of Echniococcus
granulosis. The diagnostic clue on cytology is the finding
of scolices or hooklets in the aspirates. Although a clinical
suspicion of hydatid cyst is a contraindication for FNA
because of the risk of a fatal anaphylactic reaction, no
major complications have been reported even when
hydatid cysts are inadvertently aspirated [60].
Other non-neoplastic cysts, such as simple hepatic cyst
and hepatic foregut cyst, may be aspirated to rule out
metastases in patients with a known primary malignancy.
The cytology typically consists of macrophages and few
bland appearing cuboidal, columnar, and/or squamous
epithelial cells in a background of proteinaeous fluid.
Cholangiocarcinoma Figure 4
Cholangiocarcinoma. A group of highly pleomorphic glandu-
lar cells with nuclear crowding and overlapping (Papanicolaou 
stain, ×400).
Hemangioma Figure 5
Hemangioma. The aspirate has a bloody background. High 
magnification shows rare groups of benign spindle cells. 
(insert) (Papanicolaou stain, ×40; insert: Papnicolaou stain, 
×400).World Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/5
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Among primary hepatic malignancies, biliary cystade-
noma and cystadenocarcinoma are most likely to present
as a cystic lesion. They may be an important source of false
negative cytological diagnosis because the aspirates are
often paucicellular and consists of predominantly
macrophages.
Pediatric hepatic mass
Hepatoblastoma is the most common primary hepatic
malignant neoplasm in children. It is also the third most
common intra-abdominal malignancy in childhood, fol-
lowing neuroblastoma and Wilm's tumor. Affected chil-
dren are usually 3 years old or younger and have markedly
elevated serum AFP level. The male to female ratio is 2:1.
Hepatoblastoma is not associated with cirrhosis. There are
3 histological subtypes – epithelial, anaplastic, and mixed
(epithelial and mesenchymal) [35,61]. On cytology, the
epithelial component can show a spectrum of differentia-
tion ranging from anaplastic to embryonal to fetal [62].
Anaplastic cells morphologically resemble other "small
blue cell tumors" with a uniform population of small cells
with scant cytoplasm. Embryonal cells appear as small,
oval to spindle shaped cells arranged in cords, rosettes, or
papillae (Figure 6). Individual cells have large nuclei,
small amount of cytoplasm, and prominent nucleoli.
Fetal cells are larger cells with more abundant granular
and clear cytoplasm which may contain bile, fat, or glyco-
gen. They often arrange in disorderly trabeculae, acini,
and 3-dimensional clusters. The fetal cell type may be
associated with extramedullary hematopoesis. The mesen-
chymal component, when present, appears primitive and
undifferentiated.
The differential diagnosis includes HCC which can rarely
occur in children. It is important to separate HCC from
hepatoblastoma because the latter has a better prognosis
[61]. Features that favor a diagnosis of HCC over hepato-
blastoma include patient's age greater than 10 years, pres-
ence of liver cirrhosis, more definitive hepatic
differentiation of neoplastic cells, and the presence of
marked pleomorphism and tumor giant cells [60].
Summary
FNA is a useful diagnostic test for evaluating patients with
discrete hepatic masses. However, liver FNA poses a
number of diagnostic challenges. Correlation with clini-
cal, radiological, and cytological findings is helpful in
arriving at the correct diagnosis and therefore increases
overall accuracy and cost-effectiveness of the procedure.
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